1-2 of 2
Milad Rouhimoghadam
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

LPA81: Discovery of an Exceptionally Potent Protac Degrading Native and Mutant BCR-ABL1 Oncoprotein in CML

Milad Rouhimoghadam, Hua Tang, Junzhuo Liao, Briana Bates, Daniela Uribe-Cano, Helong Zhao, Weiping Tang, Michael W. Deininger
Journal: Blood
Blood (2022) 140 (Supplement 1): 485–486.
https://doi.org/10.1182/blood-2022-158308
Published: 2022
Journal Articles

Exploiting LY3009120 and Asciminib Combination to Target TKI-Resistant CML

Milad Rouhimoghadam, Anthony D. Pomicter, Alexandria Van Scoyk, Greg Poffenberger, Ivaylo Kirov, Lyubomir G. Nashev, Helong Zhao, Martin Martinov, Michael W. Deininger
Journal: Blood
Blood (2021) 138 (Supplement 1): 3600.
https://doi.org/10.1182/blood-2021-153353
Published: 2021